Wonderful's Series C: Pay You or Dilute You

You have a term sheet in front of you, and the headline number is a new valuation. A raise can pay you, dilute you, or both, depending on whether new shares are issued and whether existing holders can sell at the round price. Wonderful closed a $550 million Series C at a $5 billion valuation, more than doubling the $2 billion mark it had nearly six months earlier. That jump alone did not make the round a payday for every holder.

The trap: a raise can look like a payday

Employees often hear 'the company raised' and assume their shares are worth more. That is sometimes true, but the money may never touch them. The trap is treating a valuation as a liquidation. A valuation is not cash in your account.

Wonderful was founded in early 2025 and raised $150 million in March at a $2 billion valuation, six months before the Series C. The round closed eighteen months after being founded. That jump matters because it changes what a share can sell for in a later transaction.

The rule: primary is new money, secondary is a sale

In a primary round, new shares are issued and cash goes to the company's balance sheet, which can reset the valuation and investor rights. The buyer pays the company, so the share count grows and existing holders own a smaller slice of a bigger pie.

Dilution is not a small rounding error. Carta's July 2026 sample of software seed rounds had a median raise of $4.1 million at a $24.3 million valuation and 18% dilution.

The secondary side is different. Existing shareholders sell shares they already hold, and the buyer pays them, not the company. If the sale happens at the round price, the holder can cash out before a public exit.

Moneybox, a UK platform, set a valuation mark of £800 million, about $1.1 billion, through a secondary. The Moneybox secondary did not create new equity or bring in fresh capital. Cash from the sale went to participating employee shareholders instead of the company's balance sheet.

For Kraken's pre-IPO secondary exposure, the shares being sold are typically already-held shares from employees, founders, or early investors. Kraken's secondary shares were trading near $35.81, a discount of roughly 42% to the prior primary price. The discount is the entry fee. It tells you how much the market is willing to pay for liquidity, risk, and time before a public exit.

Your term-sheet check: four checks that decide your outcome

When you get a term sheet, do not start with the valuation. Start with the flow of cash. The valuation is the mark. The amounts tell you who gets paid.

• Primary amount: how much new money the company is raising.
• Secondary amount: how much existing holders are selling.
• Price per share or valuation: what the round marks the company at.
• Secondary at round price: whether holders can sell at that mark.

Ask whether the secondary is open to all holders or only a selected group. A limited secondary may raise the mark for the company while paying only a few people.

Divide the valuation by the fully diluted share count to get the implied price per share. Fully diluted means counting all shares that could become real if options and warrants are exercised. Then compare that price to any secondary offer you are given.

An employee secondary is a sale by employees. It can be the difference between a valuation gain and actual cash. When you are not included, the round may still raise the mark while leaving your stake diluted.

Some rounds are mixed. The company issues new shares, and some existing holders sell in the same transaction. In that case, the primary dilutes you and the secondary may pay you if you are included.

Follow the cash: who receives it, how many new shares are created, and whether your shares are in the sale. A primary-only round dilutes you. A secondary at the round price is a reason to ask whether you can participate. A mixed round can pay you and dilute you at the same time.